With a $30 million investment, the Bruce Mitchell Research Program continues to drive excellence across disciplines, supporting new faculty appointments, and expanding opportunities for doctoral and ...

Queen’s and Bell sign Memorandum of Understanding to collaborate on a proposal to build a new supercomputing facility in Kingston.

This year brought major moments across Queen’s, from renewed campus spaces and student driven fundraising to important research milestones, athletics success, and leadership appointments. The ...

Faculty, staff, and retirees set donations record in support of programs across the Kingston, Frontenac, Lennox and Addington area.

Supercomputing expert Ian Karlin’s new role at Queen’s aims to help Canada advance its global high-performance computing capacity.

Pushing boundaries in immunology – In 2024, Paul Kubes joined Queen’s as the Canada Excellence Research Chair (CERC) in Immunophysiology and Immunotherapy. Since his arrival, he's made significant ...

The Board of Trustees has approved a report from a special committee set up in response to a student group request.

At a time when universities worldwide are competing for top research talent, Queen’s is reinforcing its role as a destination for leaders whose work drives discovery, innovation, and societal impact.

Throughout Emily Fennell’s career as a singer, songwriter, and performer, the Christmas season has always been a time that unites her favourite themes—community, generational love, and family. A Miss ...

The concept of a vampire predates Bram Stoker’s tales of Count Dracula — probably by several centuries. But did vampires ever really exist? In 1819, 80 years before the publication of Dracula, John ...

Faculty of Arts and Science PhD candidate Meghan Burry is introducing a unique cultural studies course to the Department of English curriculum this year focusing on the literacy legacy of music icon ...

Picture a computer that can perform a billion-billion operations per second. A technology capable of solving complex problems, from designing new proteins for drug treatments, vaccines, and ...